Mark leads the company’s global clinical service delivery organization, including clinical operations (project management & monitoring), global central services (biostatistics, site management & data management), and pharmacovigilance & patient safety management.
Mark joins Clinipace Worldwide through it's acquisition of Paragon Biomedical. Mark joined Paragon in 2006, and has 20+ years of CRO management experience.
He previously served as senior vice president of an international data services CRO, where he directed global project management, business development, and strategic customer relationships. Before entering the CRO field, Mark was with The Financial Relations Board, where he was responsible for the development and implementation of investor relations programs for companies in the biotechnology and healthcare industries.
Mark earned a master’s degree in journalism with an emphasis in investor relations from Michigan State University, and a Bachelor’s degree in public relations from Oklahoma Christian University.